What is aTyr Pharma's R&D?

aTyr Pharma (ATYR) reported R&D of $7.32M in Q1 2026.

How has aTyr Pharma's R&D changed year-over-year?

aTyr Pharma's R&D decreased by 38.1% year-over-year, from $11.81M to $7.32M.

What is the long-term trend for aTyr Pharma's R&D?

Over 4 years (2021 to 2025), aTyr Pharma's R&D has grown at a 26.8% compound annual growth rate (CAGR), from $23.26M to $60.22M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

aTyr Pharma ATYR R&D

R&D at other companies

Bristol-Myers SquibbBMY

$2.65B+17.4%

Merck & Co.MRK

$12.59B+248%

United TherapeuticsUTHR

$138.2M-7.2%

Design Therapeutics, Inc.DSGN

$14.38M-6.5%

CytomX TherapeuticsCTMX

$19.24M+2.0%

Vor BiopharmaVOR

$17.6M-34.1%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's R&D?: aTyr Pharma (ATYR) reported R&D of $7.32M in Q1 2026.
How has aTyr Pharma's R&D changed year-over-year?: aTyr Pharma's R&D decreased by 38.1% year-over-year, from $11.81M to $7.32M.
What is the long-term trend for aTyr Pharma's R&D?: Over 4 years (2021 to 2025), aTyr Pharma's R&D has grown at a 26.8% compound annual growth rate (CAGR), from $23.26M to $60.22M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.